Stefan Lang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stefan Lang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Bradley G. Goodyear
Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; Seaman Family MR Research Centre, Foothills Medical Centre, Calgary, AB, Canada
3 shared publicationsIsmael Gaxiola-Valdez
Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Seaman Family MR Research Centre, Foothills Medical Centre, Calgary, AB, Canada
3 shared publicationsLisa A. Partlo
Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
3 shared publications- Oury Monchi
University of Calgary
3 shared publications Paolo Federico
Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; Department of Radiology, University of Calgary, Calgary, AB, Canada; Seaman Family MR Research Centre, Foothills Medical Centre, Calgary, AB, Canada
3 shared publicationsSuneil K. Kalia
Department of Neurosurgery Toronto Western Hospital Toronto Ontario Canada
3 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 16 (1)
Network-Based Deep Brain Stimulation Rescue After Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor: Two Targeting Strategies
Background: Tremor may recur after magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, and the optimal target for deep brain stimulation (DBS) rescue remains uncertain. Cases: A 71-year-old man with recurrent essential tremor after ventral intermediate nucleus (Vim) MRgFUS underwent DBS along a Vim-posterior subthalamic area (PSA) trajectory. Microelectrode activity was attenuated in the lesioned thalamus; Vim test stimulation was ineffective, whereas PSA stimulation suppressed tremor. A 79-year-old man with recurrent tremor after staged bilateral MRgFUS underwent left DBS targeting the rubral wing. Conclusions: When the original thalamic target is anatomically or physiologically altered, targeting intact cerebellothalamic pathways provides a rational rescue strategy. Highlights Deep brain stimulation can remain effective after failed focused ultrasound thalamotomy. These cases illustrate a lesion-informed, network-based strategy that preserves access to the cerebellothalamic network when prior lesioning has altered local anatomy or physiology.
- 3 November 2026
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 16 (1)
Open AccessNetwork-Based Deep Brain Stimulation Rescue After Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor: Two Targeting Strategies
Background: Tremor may recur after magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy, and the optimal target for deep brain stimulation (DBS) rescue remains uncertain. Cases: A 71-year-old man with recurrent essential tremor after ventral intermediate nucleus (Vim) MRgFUS underwent DBS along a Vim-posterior subthalamic area (PSA) trajectory. Microelectrode activity was attenuated in the lesioned thalamus; Vim test stimulation was ineffective, whereas PSA stimulation suppressed tremor. A 79-year-old man with recurrent tremor after staged bilateral MRgFUS underwent left DBS targeting the rubral wing. Conclusions: When the original thalamic target is anatomically or physiologically altered, targeting intact cerebellothalamic pathways provides a rational rescue strategy. Highlights Deep brain stimulation can remain effective after failed focused ultrasound thalamotomy. These cases illustrate a lesion-informed, network-based strategy that preserves access to the cerebellothalamic network when prior lesioning has altered local anatomy or physiology.
- 29 July 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-12
Location of Neurostimulation Affects Short-Term Emotional Wellbeing Outcomes in Parkinson’s Disease Patients
Introduction: Emotional wellbeing is a major determinant of quality of life (QoL) in Parkinson’s disease (PD) patients. Previous studies have found mixed results regarding the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on depression and anxiety, major contributors to emotional wellbeing. There is evidence that the location of neurostimulation of the STN may explain this variability. However, studies investigating this matter have also yielded inconsistent findings. Therefore, the objective of this study was to determine the effect of STN DBS on emotional wellbeing at 6 months and 1 year and to examine whether the location of neurostimulation influences outcomes. Methods: This is a retrospective cohort study of 94 patients who received bilateral STN DBS between 2008 and 2023 in Vancouver, Canada. Emotional wellbeing was assessed using the emotional wellbeing index (EWI) of the Parkinson’s disease questionnaire-39 (PDQ-39). We divided the EWI into sub-domains assessing anxiety (EWI-A) and depression (EWI-D). We analyzed clinical outcomes using linear mixed-effect models, controlling for confounding variables. We separated the group into responders and non-responders for further analysis. For subjects with appropriate imaging (n = 18), volume of tissue activated was calculated and related to clinical outcomes, to assess for a location that led to a significant improvement in EWI, EWI-A, and EWI-D. Results: We found no significant difference in EWI at 6 months and 1 year after STN DBS at the group level. There was a significant improvement in EWI-A at 6 months (p < 0.001) and 1 year (p = 0.045). No significant difference in EWI-D was observed at either time point. 37.1% of patients in our cohort were EWI responders, while 62.9% were non-responders. Similarly at 1 year, 35.7% of patients were responders and 64.3% were non-responders. Stimulation of the dorsal STN was associated with improved EWI outcomes at 6 months, but not at 1-year (p < 0.05 FWE corrected). Conclusion: There is significant variability in EWI outcomes following STN DBS. In the imaging analysis subgroup, stimulation of the dorsal region of the STN explained some of this variability in the short-term. Improvement in motor symptoms due to DBS may be a mediating variable between location of neurostimulation in the dorsal STN and improvements in emotional wellbeing.
- 29 July 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-12
Location of Neurostimulation Affects Short-Term Emotional Wellbeing Outcomes in Parkinson’s Disease Patients
Introduction: Emotional wellbeing is a major determinant of quality of life (QoL) in Parkinson’s disease (PD) patients. Previous studies have found mixed results regarding the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on depression and anxiety, major contributors to emotional wellbeing. There is evidence that the location of neurostimulation of the STN may explain this variability. However, studies investigating this matter have also yielded inconsistent findings. Therefore, the objective of this study was to determine the effect of STN DBS on emotional wellbeing at 6 months and 1 year and to examine whether the location of neurostimulation influences outcomes. Methods: This is a retrospective cohort study of 94 patients who received bilateral STN DBS between 2008 and 2023 in Vancouver, Canada. Emotional wellbeing was assessed using the emotional wellbeing index (EWI) of the Parkinson’s disease questionnaire-39 (PDQ-39). We divided the EWI into sub-domains assessing anxiety (EWI-A) and depression (EWI-D). We analyzed clinical outcomes using linear mixed-effect models, controlling for confounding variables. We separated the group into responders and non-responders for further analysis. For subjects with appropriate imaging (n = 18), volume of tissue activated was calculated and related to clinical outcomes, to assess for a location that led to a significant improvement in EWI, EWI-A, and EWI-D. Results: We found no significant difference in EWI at 6 months and 1 year after STN DBS at the group level. There was a significant improvement in EWI-A at 6 months (p < 0.001) and 1 year (p = 0.045). No significant difference in EWI-D was observed at either time point. 37.1% of patients in our cohort were EWI responders, while 62.9% were non-responders. Similarly at 1 year, 35.7% of patients were responders and 64.3% were non-responders. Stimulation of the dorsal STN was associated with improved EWI outcomes at 6 months, but not at 1-year (p < 0.05 FWE corrected). Conclusion: There is significant variability in EWI outcomes following STN DBS. In the imaging analysis subgroup, stimulation of the dorsal region of the STN explained some of this variability in the short-term. Improvement in motor symptoms due to DBS may be a mediating variable between location of neurostimulation in the dorsal STN and improvements in emotional wellbeing.
- Open Access
- 14 August 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (12) , 2080-2091
One Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders
Background: Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors. Objective: The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second‐side surgery. Methods: This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy. Results: In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second‐side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming. Conclusions: Individualized treatment decisions are essential, with bilateral DBS providing superior long‐term outcomes for both PD and ET.
- 14 August 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (12) , 2080-2091
Open AccessOne Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders
Background: Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors. Objective: The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second‐side surgery. Methods: This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy. Results: In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second‐side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming. Conclusions: Individualized treatment decisions are essential, with bilateral DBS providing superior long‐term outcomes for both PD and ET.
- 1 January 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 140 (1) , 218-230
Computational modeling of whole-brain dynamics: a review of neurosurgical applications
A major goal of modern neurosurgery is the personalization of treatment to optimize or predict individual outcomes. One strategy in this regard has been to create whole-brain models of individual patients. Whole-brain modeling is a subfield of computational neuroscience that focuses on simulations of large-scale neural activity patterns across distributed brain networks. Recent advances allow for the personalization of these models by incorporating distinct connectivity architecture obtained from noninvasive neuroimaging of individual patients. Local dynamics of each brain region are simulated with neural mass models and subsequently coupled together, considering the subject’s empirical structural connectome. The parameters of the model can be optimized by comparing model-generated and empirical data. The resulting personalized whole-brain models have translational potential in neurosurgery, allowing investigators to simulate the effects of virtual therapies (such as resections or brain stimulations), assess the effect of brain pathology on network dynamics, or discern epileptic networks and predict seizure propagation in silico. The information gained from these simulations can be used as clinical decision support, guiding patient-specific treatment plans. Here the authors provide an overview of the rapidly advancing field of whole-brain modeling and review the literature on neurosurgical applications of this technology.
- 1 January 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 140 (1) , 218-230
Computational modeling of whole-brain dynamics: a review of neurosurgical applications
A major goal of modern neurosurgery is the personalization of treatment to optimize or predict individual outcomes. One strategy in this regard has been to create whole-brain models of individual patients. Whole-brain modeling is a subfield of computational neuroscience that focuses on simulations of large-scale neural activity patterns across distributed brain networks. Recent advances allow for the personalization of these models by incorporating distinct connectivity architecture obtained from noninvasive neuroimaging of individual patients. Local dynamics of each brain region are simulated with neural mass models and subsequently coupled together, considering the subject’s empirical structural connectome. The parameters of the model can be optimized by comparing model-generated and empirical data. The resulting personalized whole-brain models have translational potential in neurosurgery, allowing investigators to simulate the effects of virtual therapies (such as resections or brain stimulations), assess the effect of brain pathology on network dynamics, or discern epileptic networks and predict seizure propagation in silico. The information gained from these simulations can be used as clinical decision support, guiding patient-specific treatment plans. Here the authors provide an overview of the rapidly advancing field of whole-brain modeling and review the literature on neurosurgical applications of this technology.
- Open Access
- 20 April 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (6) , 933-942
Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's Disease
BackgroundDeep brain stimulation (DBS) surgery is offered to a subset of Parkinson's disease (PD) patients. It is unclear if there are features at diagnosis that predict future DBS surgery. ObjectiveTo assess predictors of eventual DBS surgery in de novo PD patients. MethodsSubjects from the Parkinson's Progression Marker Initiative (PPMI) database with newly diagnosed, sporadic PD (n = 416) were identified and stratified by their eventual DBS status (DBS+, n = 43; DBS-, n = 373). A total of 50 baseline clinical, imaging, and biospecimen features were extracted for each subject and cross-validated lasso regression was used for feature reduction. Multivariate logistic regression assessed their relationship with DBS status and a receiver operating characteristic curve evaluated model performance. Linear mixed effect models assessed disease progression over 4 years in DBS+ and DBS- patients. ResultsAge at symptom onset, Hoehn and Yahr (H&Y) stage, tremor score, and ratio of CSF Tau to amyloid-beta 1-42 (Tau: Ab) were identified as important baseline features for predicting DBS surgery. Each independently predicted DBS surgery (area under the curve = 0.83). DBS- patients had faster memory decline (P < 0.05), while DBS+ patients had faster decline in H&Y stage (P < 0.001) and motor scores (P < 0.05) prior to surgery. ConclusionThe identified features may be used for early identification of patients who may be surgical candidates during the course of their disease. Disease progression in these groups reflects surgical eligibility criteria, with DBS- patients having more rapid decline in memory while DBS+ patients experienced a faster decline in motor scores prior to DBS surgery.
- 20 April 2023
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 10 (6) , 933-942
Open AccessPredictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's Disease
BackgroundDeep brain stimulation (DBS) surgery is offered to a subset of Parkinson's disease (PD) patients. It is unclear if there are features at diagnosis that predict future DBS surgery. ObjectiveTo assess predictors of eventual DBS surgery in de novo PD patients. MethodsSubjects from the Parkinson's Progression Marker Initiative (PPMI) database with newly diagnosed, sporadic PD (n = 416) were identified and stratified by their eventual DBS status (DBS+, n = 43; DBS-, n = 373). A total of 50 baseline clinical, imaging, and biospecimen features were extracted for each subject and cross-validated lasso regression was used for feature reduction. Multivariate logistic regression assessed their relationship with DBS status and a receiver operating characteristic curve evaluated model performance. Linear mixed effect models assessed disease progression over 4 years in DBS+ and DBS- patients. ResultsAge at symptom onset, Hoehn and Yahr (H&Y) stage, tremor score, and ratio of CSF Tau to amyloid-beta 1-42 (Tau: Ab) were identified as important baseline features for predicting DBS surgery. Each independently predicted DBS surgery (area under the curve = 0.83). DBS- patients had faster memory decline (P < 0.05), while DBS+ patients had faster decline in H&Y stage (P < 0.001) and motor scores (P < 0.05) prior to surgery. ConclusionThe identified features may be used for early identification of patients who may be surgical candidates during the course of their disease. Disease progression in these groups reflects surgical eligibility criteria, with DBS- patients having more rapid decline in memory while DBS+ patients experienced a faster decline in motor scores prior to DBS surgery.
- Open Access
- 19 November 2020
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11
Preoperative Transcranial Direct Current Stimulation in Glioma Patients: A Proof of Concept Pilot Study
Background: Transcranial direct current stimulation (tDCS) has been used extensively in patient populations to facilitate motor network plasticity. However, it has not been studied in patients with brain tumors. We aimed to determine the feasibility of a preoperative motor training and tDCS intervention in patients with glioma. In an exploratory manner, we assessed changes in motor network connectivity following this intervention and relate these changes to predicted electrical field strength from the stimulated motor cortex. Methods: Patients with left-sided glioma (n=8) were recruited in an open label proof of concept pilot trial and participated in four consecutive days of motor training combined with tDCS. The motor training consisted of a 60-minute period where the subject learned to play the piano with their right hand. Concurrently, they received 40 minutes of 2 mA anodal tDCS of the left motor cortex. Patients underwent task and resting state fMRI before and after this intervention. Changes in both the connectivity of primary motor cortex (M1) and general connectivity across the brain were assessed. Patient specific finite element models were created and the predicted electrical field (EF) resulting from stimulation was computed. The magnitude of the EF was extracted from left M1 and correlated to the observed changes in functional connectivity. Results: There were no adverse events and all subjects successfully completed the study protocol. Left M1 increased both local and global connectivity. Voxel-wide measures, not constrained by a specific region, revealed increased global connectivity of the frontal pole and decreased global connectivity of the supplementary motor area. The magnitude of EF applied to the left M1 correlated with changes in global connectivity of the right M1. Conclusion: In this proof of concept pilot study, we demonstrate for the first time that tDCS appears to be feasible in glioma patients. In our exploratory analysis, we show preoperative motor training combined with tDCS may alter sensorimotor network connectivity. Patient specific modelling of EF in the presence of tumor may contribute to understanding the dose-response relationship of this intervention. Overall, this suggests the possibility of modulating neural networks in glioma patients.
- 19 November 2020
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11
Open AccessPreoperative Transcranial Direct Current Stimulation in Glioma Patients: A Proof of Concept Pilot Study
Background: Transcranial direct current stimulation (tDCS) has been used extensively in patient populations to facilitate motor network plasticity. However, it has not been studied in patients with brain tumors. We aimed to determine the feasibility of a preoperative motor training and tDCS intervention in patients with glioma. In an exploratory manner, we assessed changes in motor network connectivity following this intervention and relate these changes to predicted electrical field strength from the stimulated motor cortex. Methods: Patients with left-sided glioma (n=8) were recruited in an open label proof of concept pilot trial and participated in four consecutive days of motor training combined with tDCS. The motor training consisted of a 60-minute period where the subject learned to play the piano with their right hand. Concurrently, they received 40 minutes of 2 mA anodal tDCS of the left motor cortex. Patients underwent task and resting state fMRI before and after this intervention. Changes in both the connectivity of primary motor cortex (M1) and general connectivity across the brain were assessed. Patient specific finite element models were created and the predicted electrical field (EF) resulting from stimulation was computed. The magnitude of the EF was extracted from left M1 and correlated to the observed changes in functional connectivity. Results: There were no adverse events and all subjects successfully completed the study protocol. Left M1 increased both local and global connectivity. Voxel-wide measures, not constrained by a specific region, revealed increased global connectivity of the frontal pole and decreased global connectivity of the supplementary motor area. The magnitude of EF applied to the left M1 correlated with changes in global connectivity of the right M1. Conclusion: In this proof of concept pilot study, we demonstrate for the first time that tDCS appears to be feasible in glioma patients. In our exploratory analysis, we show preoperative motor training combined with tDCS may alter sensorimotor network connectivity. Patient specific modelling of EF in the presence of tumor may contribute to understanding the dose-response relationship of this intervention. Overall, this suggests the possibility of modulating neural networks in glioma patients.
- Open Access
- 1 September 2020
- Published by Wiley in Human Brain Mapping
- Vol. 41 (13) , 3749-3764
Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
Parkinson's disease (PD) is characterized by overlapping motor, neuropsychiatric, and cognitive symptoms. Worse performance in one domain is associated with worse performance in the other domains. Commonality analysis (CA) is a method of variance partitioning in multiple regression, used to separate the specific and common influence of collinear predictors. We apply, for the first time, CA to the functional connectome to investigate the unique and common neural connectivity underlying the interface of the symptom domains in 74 non-demented PD subjects. Edges were modeled as a function of global motor, cognitive, and neuropsychiatric scores. CA was performed, yielding measures of the unique and common contribution of the symptom domains. Bootstrap confidence intervals were used to determine the precision of the estimates and to directly compare each commonality coefficient. The overall model identified a network with the caudate nucleus as a hub. Neuropsychiatric impairment accounted for connectivity in the caudate-dorsal anterior cingulate and caudate-right dorsolateral prefrontal-right inferior parietal circuits, while caudate-medial prefrontal connectivity reflected a unique effect of both neuropsychiatric and cognitive impairment. Caudate-precuneus connectivity was explained by both unique and shared influence of neuropsychiatric and cognitive symptoms. Lastly, posterior cortical connectivity reflected an interplay of the unique and common effects of each symptom domain. We show that CA can determine the amount of variance in the connectome that is unique and shared amongst motor, neuropsychiatric, and cognitive symptoms in PD, thereby improving our ability to interpret the data while gaining novel insight into networks at the interface of these symptom domains.
- 1 September 2020
- Published by Wiley in Human Brain Mapping
- Vol. 41 (13) , 3749-3764
Open AccessCommon and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
Parkinson's disease (PD) is characterized by overlapping motor, neuropsychiatric, and cognitive symptoms. Worse performance in one domain is associated with worse performance in the other domains. Commonality analysis (CA) is a method of variance partitioning in multiple regression, used to separate the specific and common influence of collinear predictors. We apply, for the first time, CA to the functional connectome to investigate the unique and common neural connectivity underlying the interface of the symptom domains in 74 non-demented PD subjects. Edges were modeled as a function of global motor, cognitive, and neuropsychiatric scores. CA was performed, yielding measures of the unique and common contribution of the symptom domains. Bootstrap confidence intervals were used to determine the precision of the estimates and to directly compare each commonality coefficient. The overall model identified a network with the caudate nucleus as a hub. Neuropsychiatric impairment accounted for connectivity in the caudate-dorsal anterior cingulate and caudate-right dorsolateral prefrontal-right inferior parietal circuits, while caudate-medial prefrontal connectivity reflected a unique effect of both neuropsychiatric and cognitive impairment. Caudate-precuneus connectivity was explained by both unique and shared influence of neuropsychiatric and cognitive symptoms. Lastly, posterior cortical connectivity reflected an interplay of the unique and common effects of each symptom domain. We show that CA can determine the amount of variance in the connectome that is unique and shared amongst motor, neuropsychiatric, and cognitive symptoms in PD, thereby improving our ability to interpret the data while gaining novel insight into networks at the interface of these symptom domains.
- Open Access
- 6 April 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 67 (12) , 3327-3338
Impact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study
Background: Tumor treatment fields (TTFields) are an approved adjuvant therapy for glioblastoma (GBM). The magnitude of applied electrical field has been shown to be related to the anti-tumoral response. However, peritumoral edema may result in shunting of electrical current around the tumor, thereby reducing the intra-tumoral electric field. In this study, we systematically address this issue with computational simulations. Methods: Finite element models are created of a human head with varying amounts of peritumoral edema surrounding a virtual tumor. The electric field distribution was simulated using the standard TTFields electrode montage. Electric field magnitude was extracted from the tumor and related to edema thickness. Two patient specific models were created to confirm these results. Results: The inclusion of peritumoral edema decreased the average magnitude of the electric field within the tumor. In the model considering a frontal tumor and an anterior-posterior electrode configuration, ≥6 mm of peritumoral edema decreased the electric field by 52%. In the patient specific models, peritumoral edema decreased the electric field magnitude within the tumor by an average of 26%. The effect of peritumoral edema on the electric field distribution was spatially heterogenous, being most significant at the tissue interface between edema and tumor. Conclusions: The inclusion of peritumoral edema during TTFields modelling has a dramatic effect on the predicted electric field magnitude within the tumor. Given the importance of electric field magnitude for the anti-tumoral effects of TTFields, the presence of edema should be considered both in future modelling studies and when planning TTField therapy.
- 6 April 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 67 (12) , 3327-3338
Open AccessImpact of Peritumoral Edema During Tumor Treatment Field Therapy: A Computational Modelling Study
Background: Tumor treatment fields (TTFields) are an approved adjuvant therapy for glioblastoma (GBM). The magnitude of applied electrical field has been shown to be related to the anti-tumoral response. However, peritumoral edema may result in shunting of electrical current around the tumor, thereby reducing the intra-tumoral electric field. In this study, we systematically address this issue with computational simulations. Methods: Finite element models are created of a human head with varying amounts of peritumoral edema surrounding a virtual tumor. The electric field distribution was simulated using the standard TTFields electrode montage. Electric field magnitude was extracted from the tumor and related to edema thickness. Two patient specific models were created to confirm these results. Results: The inclusion of peritumoral edema decreased the average magnitude of the electric field within the tumor. In the model considering a frontal tumor and an anterior-posterior electrode configuration, ≥6 mm of peritumoral edema decreased the electric field by 52%. In the patient specific models, peritumoral edema decreased the electric field magnitude within the tumor by an average of 26%. The effect of peritumoral edema on the electric field distribution was spatially heterogenous, being most significant at the tissue interface between edema and tumor. Conclusions: The inclusion of peritumoral edema during TTFields modelling has a dramatic effect on the predicted electric field magnitude within the tumor. Given the importance of electric field magnitude for the anti-tumoral effects of TTFields, the presence of edema should be considered both in future modelling studies and when planning TTField therapy.
- Open Access
- 1 January 2020
- Published by Elsevier in NeuroImage: Clinical
- Vol. 26, 102252
Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity
- 1 January 2020
- Published by Elsevier in NeuroImage: Clinical
- Vol. 26, 102252
Open AccessMild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity